摘要
目的探讨丁苯酞注射液、依达拉奉联用于急性脑梗死患者治疗中的价值。方法按照随机数字表法将2016年1月—2017年1月84例急性脑梗死患者分组。对照组采用丁苯酞注射液治疗,联合组给予丁苯酞注射液、依达拉奉联用。比较两组急性脑梗死预后效果;用药前后神经功能缺损水平、独立生活能力;干预前后患者血循环指标。结果联合组急性脑梗死预后效果高于对照组,干预后联合组神经功能缺损水平、独立生活能力、血循环指标优于对照组,P<0.05。结论丁苯酞注射液、依达拉奉联用于急性脑梗死患者治疗中的价值高。
Objective To investigate the value of butylphthalide injection and edaravone in the treatment of patients with acute cerebral infarction. Methods According to the random number table method, 84 patients with acute cerebral infarction were divided into two groups from January 2016 to January 2017. The control group was treated with butylphthalide injection, the combination group was given butylphthalide injection, edaravone combination. The prognosis of acute cerebral infarction was compared between two groups. The level of neurological deficits and independent living ability before and after treatment were compared before and after the intervention. Results The prognosis of acute cerebral infarction in the combined group was higher than that of the control group. The levels of neurological deficit, independent living ability and blood circulation in the combined group were better than those in the control group after intervention （P 〈 0.05）. Conclusion Butylphthalide injection and edaravone combined with high value in the treatment of patients with acute cerebral infarction.
出处
《中国卫生标准管理》
2017年第27期88-89,共2页
China Health Standard Management
关键词
丁苯酞注射液
依达拉奉
急性脑梗死患者
治疗价值
butylphthalide injection
edaravone
patients with acute cerebral infarction
therapeutic value
